Protagenic Therapeutics, Inc.\new Other Comprehensive Income (Loss), Net of Tax
Protagenic Therapeutics, Inc.\new (PTIX) reported Other Comprehensive Income (Loss), Net of Tax of -$1.07 thousand for the 12-month period ending 2015-12-31, per its 8-K/A filed 2016-07-12.
Discontinued › Income Statement › Unrealized Gains
us-gaap:OtherComprehensiveIncomeLossNetOfTax · last filed 2016-07-12
| Period end | Other Comprehensive Income (Loss), Net of Tax 12 month |
|---|---|
| 2015-12-31 | -$1.07K 8-K/A · filed 2016-07-12 |
| 2014-12-31 | -$156.34K 8-K/A · filed 2016-07-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| Nexentis Technologies Inc. (NXTS) | $0.002B | ||
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| CDT Equity Inc. (CDT) | United States | $0.000B | -0.01 |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| Aditxt, Inc. (ADTX) | United States | $0.000B | |
| Rafael Holdings, Inc. (RFL) | United States | $0.000B | -0.00 |